News

Open position

Posted on

In the framework of a multidisciplinary project, the CEA Fundamental Research Division, in collaboration with the CEA LETI et the CEA LITEN, develops novel approaches toward the characterization of viral particles in aerosol phase.  In this context, we are seeking a research engineer specialized in fluid mechanics.  Read the complete description. 

News

Newborn !

Posted on

The FAIMS interface has just been installed on our new Orbitrap Exploris 480. This new MS instrument will enlarge our analytical capabilities.

News

Open PhD position

Posted on

Delphine Pflieger is seeking a motivated student to perform a PhD starting in October 2021.  Briefly, the project aims at better understanding the molecular dysfunctions at stake in the rare neurodegenerative disease called Huntington’s disease, which results in motor, cognitive and psychiatric symptoms. More specifically, we want to decipher how perturbations of histone modifications lead […]

News

Offre d’emploi

Posted on

Pour participer à son activité de R&D et de service à la communauté, l’équipe EDyP, localisée à Grenoble, recherche un/une ingénieur(e) d’Etudes en analyses protéomiques basées sur la spectrométrie de masse. Au sein de l’équipe EDyP (Exploration de la Dynamique des Protéomes, edyp.fr), vous mettrez en oeuvre un ensemble de techniques et méthodes analytiques et […]

News

ProteoRE version 2.1 is released

Posted on

We are pleased to announce the release of ProteoRE 2.1, a user-oriented Galaxy-based instance, for the functional interpretation and exploration of proteomics data for biomedical research; This version now comprises 20 tools organized in 4 sections (data manipulation and visualization; add features/annotation; functional analysis;  pathways analysis. All data sources have been updated. Three new tools […]

Applications

Hepatitis

Posted on

Identifying HBc nuclear regulatory functions Despite the existence of a preventive vaccine, chronic infections with Hepatitis B virus (HBV) remain a major health problem worldwide, and represent the first cause of liver cancer. Current clinically accepted antivirals treatments generally lead to a significant reduction of viremia in the blood of patients. However, the liver viral […]